Healthcare -
Biotechnology - NASDAQ - US
$ 0.3401
-5.11 %
$ 3.83 M
Market Cap
-0.01
P/E
CYCC - ACCOUNTS PAYABLE
Accounts Payable CYCC - Cyclacel Pharmaceuticals, Inc.
3.54 M
LAST VALUE
29.37%
2 YEAR CAGR
5.44%
5 YEAR CAGR
3.36%
10 YEAR CAGR